ClinicalTrials.gg
CompletedNCT06816316Updated Feb 24, 2025

Role of Alcohol in Prevention of Recurrence of the Accidentally Opened Angular Dermoid Cyst

An interventional study of external angular dermoid cysts surgical removal in Dermoid Cyst and Choristomas, sponsored by Beni-Suef University. Completed at 3 sites in Egypt. Open to participants aged 1 Year to 12 Years. Per ClinicalTrials.gov, last updated 2025-02-24.

Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 3 months after the study started (first participant enrolled Jan 2019, registered Apr 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
1 Year to 12 Years
Sex
All
01

Study summary

Purpose to evaluate the effect of alcohol used in accidentally opened dermoid cyst in prevention of inflammation and recurrence Patient and method: Itt is a comparative interventional study ,performed on 60 patients with external angular dermoid cysts that were accidentally opened during surgical removal , they were divided into two groups ,Group (A) includes 30 patients where only saline was used to wash the surgical field while group(B) includes 30 patients where ethyl alcohol 70% was used.

Read the detailed description
  1. Study Design and Rationale:

    This is a comparative interventional study designed to evaluate the efficacy of 70% ethyl alcohol in preventing inflammation and recurrence in cases of accidentally opened external angular dermoid cysts during surgical removal. The rationale for using 70% ethyl alcohol is based on its antimicrobial and antiseptic properties, which may reduce the risk of postoperative infection and cyst recurrence compared to saline irrigation alone.

  2. Patient Recruitment and Group Allocation:

    Recruitment Sites: Patients were recruited from outpatient clinics at Beni-Suef University Hospitals, Fayoum University Hospitals, and MUST University Hospital.

    Recruitment Period: May 2022 to May 2024.

    Group Allocation:

    Group A (Control Group): 30 patients treated with saline irrigation.

    Group B (Intervention Group): 30 patients treated with 70% ethyl alcohol.

  3. Surgical Procedure:

    Preoperative Preparation:

    Patients were positioned supine, and the surgical site was sterilized using standard antiseptic protocols.

    Local or general anesthesia was administered based on patient and surgeon preference.

    Incision and Dissection:

    A skin incision was made below the eyebrow, followed by subcutaneous and orbicularis dissection to expose the dermoid cyst.

    Care was taken to avoid accidental rupture, but if the cyst was opened, the following steps were implemented.

    Cyst Management:

    The cyst walls and contents were meticulously removed from the surgical field to minimize residual material.

    Group A (Saline Group): The surgical field was irrigated with sterile saline solution to remove any remnants.

    Group B (Alcohol Group): The surgical field was cleaned using a gauze soaked with 70% ethyl alcohol to ensure thorough disinfection.

    Wound Closure:

    The wound was closed in layers using absorbable sutures for subcutaneous tissues and non-absorbable sutures or skin adhesive for the skin.

    A sterile dressing was applied.

  4. Postoperative Care:

    Medications:

    Both groups received the same regimen of systemic antibiotics (e.g., amoxicillin-clavulanate) and anti-inflammatory drugs (e.g., ibuprofen) for 5-7 days to prevent infection and inflammation.

    Follow-Up:

    Patients were monitored at 1 week, 1 month, 3 months, and 6 months postoperatively.

    At each visit, the surgical site was assessed for signs of inflammation, infection, or recurrence.

    Any adverse events or complications were recorded.

  5. Data Collection and Analysis:

    Data Collected:

    Demographic data (age, sex).

    Intraoperative details (cyst size, extent of spillage).

    Postoperative outcomes (infection, inflammation, recurrence).

    Statistical Methods:

    Data were analyzed using SPSS version 24.

    Quantitative variables (e.g., cyst size) were summarized as mean ± standard deviation.

    Categorical variables (e.g., recurrence rates) were summarized as frequencies and percentages.

    Comparisons between groups were performed using:

    ANOVA with post hoc tests for continuous variables.

    Chi-square test or Fisher's exact test for categorical variables.

    Pearson correlation coefficient was used to assess relationships between quantitative variables.

    A p-value \< 0.05 was considered statistically significant.

  6. Technical Considerations:

    Ethyl Alcohol Concentration: 70% ethyl alcohol was chosen for its optimal balance between antimicrobial efficacy and tissue safety.

    Saline Irrigation: Sterile saline was used as a control to mimic standard surgical practice.

    Standardization: All procedures were performed by experienced surgeons to ensure consistency in technique and cyst management.

  7. Ethical and Regulatory Compliance:

    Informed Consent: Written informed consent was obtained from all participants prior to surgery.

    Ethical Approval: The study protocol was approved by the Ethics Committee of Beni-Suef University and adhered to the principles of the Helsinki Declaration.

    Patient Safety: Adverse events were monitored and managed promptly to ensure patient safety.

  8. Limitations:

    The study is limited by its sample size (n=60), which may affect the generalizability of the results.

    The follow-up period of 6 months may not be sufficient to capture long-term recurrence rates.

    Potential variability in surgical technique among different surgeons.

  9. Expected Outcomes:

The study aims to demonstrate that 70% ethyl alcohol is more effective than saline in reducing postoperative inflammation and recurrence in accidentally opened dermoid cysts.

If proven effective, this intervention could be incorporated into standard surgical protocols for dermoid cyst management.

02

Conditions studied

  • Dermoid Cyst
  • Choristomas

Keywords

  • dermoid cyst
  • ethyl alcohol
  • choristomas
  • lipogranulomatous inflammatory
03

In context

Lead sponsor

Beni-Suef University is the lead sponsor of 349 studies on the registry; 123 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Clinical diagnosis of external angular dermoid cyst.

Accidental opening of the dermoid cyst during surgical removal.

Age: Patients of any age eligible for surgical intervention.

Willingness to provide written for participation in the study.

Exclusion criteria

Exclusion Criteria:

Recurrent dermoid cysts (previously treated or excised).

Complicated dermoid cysts (e.g., preoperatively ruptured or infected).

Patients with to the use of ethyl alcohol (e.g., known or allergy).

Patients with systemic conditions that may impair wound healing (e.g., uncontrolled diabetes, states).

Patients who are pregnant or breastfeeding.

Patients unable or unwilling to comply with follow-up visits.

Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Placebo comparator
    Group (A)

    only saline was used to wash the surgical field

    Procedure: external angular dermoid cysts surgical removal

  • Active comparator
    group (B)

    ethyl alcohol 70% was used to wash the surgical field

    Procedure: external angular dermoid cysts surgical removal

Interventions

  • Procedureexternal angular dermoid cysts surgical removal

    Skin incision was done below the eyebrow, subcutaneous and orbicularis dissection was done to remove the cysts. Upon accidental opening of the cyst then removal of the cyst walls and its contents from the surgical field as much as possible was done. At this step, in group (A) only saline was used to wash the surgical field from any remnants. In group (B) the surgical field was cleaned with a gauze soaked with ethyl alcohol 70%. Then closure of the wound in both groups.

06

What researchers measure

Primary outcomes

  1. post-operative inflammation

    The primary outcome of post-operative inflammation measures the incidence of clinically significant inflammatory responses at the surgical site following excision of an accidentally opened external angular dermoid cyst. Inflammation is defined as the presence of two or more of the following clinical signs: Erythema (redness) extending ≥1 cm from the wound edges. Edema (swelling) at or around the surgical site. Local warmth compared to adjacent skin. Pain or tenderness reported by the patient or elicited during palpation. Purulent discharge from the incision site.

    Time frame: 6 month

Secondary outcomes

  1. recurrence

    The recurrence outcome measures the number of participants who experience a reappearance of the external angular dermoid cyst at the surgical site within the 6-month follow-up period after surgical removal. Recurrence is defined as the presence of a palpable mass or radiologically confirmed lesion (via ultrasound or MRI) that exhibits characteristics consistent with a dermoid cyst. This outcome is a critical measure of the long-term efficacy of the surgical intervention and the intraoperative cleaning method (saline vs. 70% ethyl alcohol) in preventing residual cyst material from causing regrowth.

    Time frame: 6 month

07

Study locations

3 sites
  • Beni Suef University
    Banī Suwayf, Egypt
  • Fayoum University Hospital
    Fayoum, Egypt
  • Misr University For Science and Technology
    Giza, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2019 to primary completion in Dec 2023, 59 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 28, 2024
First posted
Feb 10, 2025
StartActual
Jan 1, 2019
Primary completionActual
Dec 31, 2023
CompletionActual
May 30, 2024
Last update
Feb 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06816316
Responsible party
Mohamed Yasser Sayed Saif (Dean of National Institute of Longevity Elder Sciences - Professour of Ophthalmology, Beni-Suef University) — Principal investigator
First posted
Feb 10, 2025
Start date
Jan 1, 2019
Primary completion
Dec 31, 2023
Completion
May 30, 2024
Last update
Feb 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion